Category: Research (Page 8 of 93)

FDA Bans BPA From Baby Bottles And Sippy Cups

The FDA has finally publicly recognized the dangers of BPA in plastics and the environment.

The ban is based on concerns voiced by the American Chemistry Council which encouraged the FDA to phase out use of BPA in these particular products.

This was designed in part to counter years of negative publicity from consumer groups.

The dangers of BPA in the environment and their effect on all humans have raised red flags for years.

Previous research in animals has associated BPA exposure to disruptions in reproductive and nervous-system development in babies, but the FDA has long maintained that such findings cannot be applied to humans. Other observational studies in humans have associated prenatal exposure to the chemical with behavior problems and childhood asthma. Just this week, the journal Pediatrics published a study linking BPA in dental fillings to problems like depression and anxiety in kids.

Some 96% of pregnant women have measurable levels of BPA, according to a 2011 study by University of California, San Francisco, researchers; in fact, data show that nearly every American has traces of BPA in their urine from exposure to food and beverage packaging.

For now, the federal government maintains that BPA does not harm humans, but it is spending $30 million on its own studies to assess the chemical’s health effects on humans.

The FDA Has Approved The Diet Drug Qsymia

The FDA has approved Qsymia for use today by those who are obese, with a BMI of 30 or more, or for those who have a BMI of 27 with weight related illness.

The history of weight loss pills has been fraught with law suits due to life threatening side affects and prescription abuse by physicians and patients.

The major problem with weight loss drugs is that they don’t address the underlying causes of weight gain such as the psychological component of over eating and the food itself.

There is wide ranging debate regarding the way certain processed and scientifically engineered foodstuffs react with human physiology and metabolism.

Until we confront these two major issues surrounding food it will be difficult to solve America’s obesity epidemic with a pill.

“Given the literally insatiable appetite of doctors and patients for new drugs as a quick fix for obesity, there is every reason to believe that, if approved, a combination like this, will be used by millions, over long periods of time far beyond its labeling indications. Because of a long list of safety reasons, this drug should not be approved,” the group’s Dr. Sidney Wolfe told the FDA advisory panel in 2010.
Vivus, the company that makes Qsymia, hopes it will be a safer successor to the notorious and now banned “fen-phen” diet cocktail. Fen-phen combined fenfluramine and phentermine — one of the two drugs in Qsymia — but it damaged the heart in some cases and caused a condition in some patients called pulmonary hypertension, which causes fluid to build up in the chest, bringing a feeling of breathlessness.

5 Undesirable Traits That We Inherit

Baldness, Color Blindness, Lactose Intolerance, Acne and Heart Disease are traits which are genetic.

In an age when we do everything possible to be our best there are some things we just can’t change.
Colorblindness affects about 10 percent of men but less than 1 percent of women. It is directly inherited, and here’s why it’s more common in men: Genes for the eye’s red and green receptors sit near each other on the X-chromosome. Men have one X-chromosome, which they inherit from their mother; women have two, and a good gene will often balance out a defective one. Ninety-nine percent of cases involve the challenge of distinguishing between reds and greens. Complete colorblindness, or achromatopsia, is rare, affecting about one in 30,000 people worldwide. Interestingly, colorblind people dream in whatever colors they normally distinguish when awake.

« Older posts Newer posts »

© 2026 MedClient.com

Theme by Anders NorenUp ↑